Kisplyx Եվրոպական Միություն - ռումիներեն - EMA (European Medicines Agency)

kisplyx

eisai gmbh - lenvatinib mesilate - carcinomul, celula renală - agenți antineoplazici - kisplyx is indicated for the treatment of adults with advanced renal cell carcinoma (rcc):in combination with pembrolizumab, as first-line treatment (see section 5. in combination with everolimus, following one prior vascular endothelial growth factor (vegf)-targeted therapy.

CISPLATINA ACCORD 1 mg/ml Ռումինիա - ռումիներեն - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

cisplatina accord 1 mg/ml

accord healthcare limited - marea britanie - cisplatinum - conc. pt. sol. perf. - 1mg/ml - alte antineoplazice compusi ai platinei

CISPLATINA ACCORD 1 mg/ml Ռումինիա - ռումիներեն - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

cisplatina accord 1 mg/ml

accord healthcare polska sp. z.o.o. - polonia - cisplatinum - conc. pt. sol. perf. - 1mg/ml - alte antineoplazice compusi ai platinei